<DOC>
	<DOC>NCT00665054</DOC>
	<brief_summary>Purpose of the study is:- To assess the efficacy and tolerability of vardenafil in male subjects suffering from erectile dysfunction as compared to placebo- To assess the influence of vardenafil on the self-esteem and self-confidence of subjects suffering from erectile dysfunction following treatment with vardenafil as compared to placebo</brief_summary>
	<brief_title>BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Men with heterosexual relationships aged 18 64 years suffering from ED for more than 6 months according to the NIH Consensus Statement (i.e. inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance). At least 4 attempts at sexual intercourse (according to the question in the subject diary) on 4 separate days during the 4week untreated baseline period. At least 50% of attempts during this period had to be unsuccessful according to the subject diary. Presence of penile anatomical abnormalities (eg penile fibrosis or Peyronie's disease) that in the investigator's opinion would significantly impair sexual performance. Primary hypoactive sexual desire.Spinal cord injuryHistory of surgical prostatectomy (transurethral interventions not excluded). Unstable angina pectoris. History of myocardial infarction, stroke or lifethreatening arrhythmia within the prior 6 months. Uncontrolled atrial fibrillation/flutter at screening visit (ventricular response rate &gt;100 BPM).</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Vardenafil</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>SSES-E (sexual self-efficacy scale - erectile function)</keyword>
</DOC>